Torrent Pharmaceuticals Limited Diltiazem Export Data — India (DGFT 2022–2026)

Name: Torrent Pharmaceuticals Limited Diltiazem Export Records India — #13 Exporter, 8 Shipments, $400.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Diltiazem

India Pharmaceutical Trade Intelligence

$18.0M184 Suppliers71 CountriesHS 30049079

ExportsIndia → UNITED STATES62.4%India → CANADA18.8%

ImportsUNITED KINGDOM → India$760.0K UNITED STATES → India$155.5K

#1 Supplier: EMCURE PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Torrent Pharmaceuticals Limited — Diltiazem Exporter #13 | $400.0K Trade Value | TransData Nexus | TransData Nexus

Torrent Pharmaceuticals Limited — Diltiazem Exporter Profile

Indian Pharmaceutical Exporter · #13 for Diltiazem · $400.0K export value · DGFT Verified

Torrent Pharmaceuticals Limited is the #13 Indian exporter of Diltiazem with $400.0K in export value and 8 verified shipments. Torrent Pharmaceuticals Limited holds a 2.2% market share in Diltiazem exports across 1 countries. The company exports 43 pharmaceutical products worth $219.4M across 18 therapeutic categories.

Torrent Pharmaceuticals Limited — Diltiazem Export Profile: Buyers & Destinations

Torrent Pharmaceuticals Limited Diltiazem export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Diltiazem?

Country	Value	Shipments	Share
UNITED STATES	$10.3M	207	61.3%
CANADA	$3.4M	133	20.1%
SRI LANKA	$1.6M	85	9.4%
UNITED ARAB EMIRATES	$555.9K	206

Who Are the Top Buyers of Diltiazem from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$2.3M	47
MARCAN PHARMACEUTICALS INC.	CANADA	$1.6M	57
TEVA PHARMACEUTICALS USA, INC	UNITED STATES	$1.4M	27
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$1.1M	22
MARCAN PHARMACEUTICALS INC.,	CANADA	$1.0M	40
MARCAN PHARMACEUTICALS INC	CANADA	$700.5K	27
MYLAN PHARMACEUTICALS INC	UNITED STATES	$686.9K	18
EUGIA US LLC	UNITED STATES	$450.0K	9
EVERSANA LIFESCIENCE SERVICES	UNITED STATES	$400.0K	8
J. KNIPPER & COMPANY	UNITED STATES	$250.0K	5

India's Diltiazem is purchased by 298 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by MARCAN PHARMACEUTICALS INC. and TEVA PHARMACEUTICALS USA, INC.

How Does Torrent Pharmaceuticals Limited Compare to Nearest Diltiazem Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	ALTAIR LIFESCIENCE	$518.7K	97	1	$5.3K
12	INVENTIA HEALTHCARE LIMITED	$504.2K	36	1	$14.0K
13	TORRENT PHARMACEUTICALS LIMITED ★	$400.0K	8	1	$50.0K
11	ALEMBIC PHARMACEUTICALS LIMITED	$250.0K	5	1	$50.0K
14	CADILA HEALTHCARE LTD	$200.0K	4	1	$50.0K

Torrent Pharmaceuticals Limited ranks #13 among 184 Indian Diltiazem exporters. Average shipment value of $50.0K compared to the market average of $78.0K. The closest competitors by value are ALTAIR LIFESCIENCE and INVENTIA HEALTHCARE LIMITED.

Which Indian Ports Ship Diltiazem Exports?

Port	Shipments	% Share
SAHAR AIR	357	19.6%
SAHAR AIR CARGO ACC (INBOM4)	302	16.6%
DELHI AIR CARGO ACC (INDEL4)	201	11.0%
NHAVA SHEVA SEA (INNSA1)	181	9.9%
DELHI AIR	155	8.5%
Bombay Air	100	5.5%
JNPT/ NHAVA SHEVA SEA	52	2.9%
Delhi Air	36	2.0%

Geopolitical & Trade Policy Impact on Torrent Pharmaceuticals Limited's Diltiazem Exports

The global pharmaceutical export landscape is currently navigating a series of geopolitical challenges that have direct implications for Indian exporters like Torrent Pharmaceuticals.

The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to the Middle East and North Africa (MENA) region. Maritime carriers have suspended bookings and rerouted shipments via the Cape of Good Hope, resulting in longer transit times and increased shipping costs. These disruptions are particularly concerning for time-sensitive pharmaceutical products, as extended lead times can affect product efficacy and shelf life. (pharmaceuticalcommerce.com)

In the United States, recent tariff policies have introduced additional complexities. The U.S. administration's imposition of broad tariffs on imports from over 60 countries, including India, has raised concerns about the competitiveness of Indian pharmaceutical products in the U.S. market. While health products have been exempted from these tariffs, the potential for future policy changes necessitates vigilance. (apnews.com)

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive (FMD). Indian exporters must ensure adherence to these regulations to maintain market access. Non-compliance could result in significant market share losses in the EU, a key export destination for Torrent Pharmaceuticals.

Torrent Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Quality compliance remains a critical focus for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has intensified inspections of Indian manufacturing facilities, conducting over 200 inspections in 2023, with plans to increase this number in 2024. This heightened scrutiny underscores the importance of adhering to Good Manufacturing Practices (GMP) to ensure product quality and maintain export eligibility. (fact.net.in)

Torrent Pharmaceuticals has proactively addressed these regulatory challenges by investing in quality control systems and infrastructure. The company's commitment to compliance is evident in its consistent financial performance and sustained market presence. However, the broader Indian pharmaceutical sector continues to grapple with issues related to counterfeit drugs and quality concerns, which can impact the reputation of even compliant companies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Diltiazem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Torrent Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 71+ countries, 298+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Diltiazem

Diltiazem

Torrent Pharmaceuticals Limited — Diltiazem Exporter Profile

Torrent Pharmaceuticals Limited — Diltiazem Export Profile: Buyers & Destinations

Where Does India Export Diltiazem?

Who Are the Top Buyers of Diltiazem from India?

What Is India's Total Diltiazem Export Value and How Much Does Torrent Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Torrent Pharmaceuticals Limited's Diltiazem Exports?

How Does Torrent Pharmaceuticals Limited Compare to Other Indian Diltiazem Exporters?

Regulatory Requirements: Exporting Diltiazem to Key Markets

United States — FDA

Canada — HC

How Does Torrent Pharmaceuticals Limited Compare to Nearest Diltiazem Exporters?

Which Indian Ports Ship Diltiazem Exports?

Geopolitical & Trade Policy Impact on Torrent Pharmaceuticals Limited's Diltiazem Exports

Torrent Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Torrent Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Diltiazem Export Data from Torrent Pharmaceuticals Limited

Diltiazem Stats

Company Overview

Top Products by Torrent Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source